Massachusetts Hospital Utilizes New Method for Detecting Colorectal Cancer

Quincy (Mass.) Medical Center has been tapped to conduct a new clinical trial that would assess the efficacy of a GI device aimed at detecting more abnormalities during colonoscopy, according to a Boston Globe news report.

Advertisement

The Third Eye device enables GI physicians to view a 360-degree image of patients’ colons, which reduces the risk of missing colorectal polyps. The device, which is FDA approved, is contained within a traditional colonoscopy but allows physicians to view up to 25 percent more colon abnormalities than a routine colonoscopy, according to the news report.

Read the news report about use of the Third Eye device at Quincy Medical Center.

Read other coverage about colonoscopy:

Detection of Premalignant Colon Polyps Stable Throughout Workday Under Certain Conditions

Position Changes During Colonoscope Withdrawal Can Increase Adenoma Detection Rate

Study: Polypectomy Rate Can Be Used as Quality Measure

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.